FARXIGA

Farxiga is the brand name for the medication dapagliflozin. It belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. Farxiga is primarily used to treat type 2 diabetes, but it may also be prescribed for certain cardiovascular conditions. The primary action of Farxiga is to lower blood sugar levels by reducing the reabsorption of glucose by the kidneys and increasing urinary glucose excretion. This mechanism helps to remove excess glucose from the body through urine, thereby lowering blood glucose levels. .